BackCardiac Biotech Solutions Overview

Cardiac Biotech Solutions Receivables

Cardiac Biotech Solutions's receivables is $89K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$88634.00
↑ 110.24% YoYΔ $46476.00 vs prior year quarter

Peer trimmed avg / median

Loading

Cardiac Biotech Solutions Receivables History

Loading

Cardiac Biotech Solutions vs. peers: Receivables Comparison

Loading

Cardiac Biotech Solutions Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cardiac Biotech Solutions (CBSC) FAQ

As of the most recent data (June 2026), CBSC shows a receivables of $89K. That compares with $42K in the prior-year period — up 110.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CBSC's receivables is now $89K (was $42K) — a 110.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cardiac Biotech Solutions is outperforming or lagging.

Tracking CBSC's receivables over time shows whether Cardiac Biotech Solutions is scaling, shrinking, or reshaping that part of the business. The current reading is $89K That compares with $42K in the prior-year period — up 110.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Cardiac Biotech Solutions's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $89K) with ownership activity and broader fundamentals.